Results 1 to 10 of about 1,361,764 (281)

Autologous stem-cell transplantation for multiple myeloma: a Brazilian institution experience in 15 years of follow-up [PDF]

Einstein (São Paulo), 2011
Objective: To determine the 5-year post-transplant survival of patients with multiple myeloma. Methods: A retrospective study in patients diagnosed with multiple myeloma submitted to autologous bone marrow transplantation at a Brazilian institution ...
Juliana Todaro, Ana Rita de Araújo Burgos Manhani, José Mauro Kutner, Andreza Alice Feitosa Ribeiro, Morgani Rodrigues, Fabio Rodrigues Kerbauy, Jairo Nascimento Sobrinho, Eurípedes Ferreira, Nelson Hamerschlak   +8 more
doaj   +3 more sources

EVALUATION OF COMMON INTERACTIONS INCLUDING ANTI-INFECTIVE DRUGS IN PATIENTS UNDERWENT AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION

Hematology, Transfusion and Cell Therapy, 2021
Objective: Hematopoietic stem cell transplantation is a challenging process involving polypharmacy. Drug-drug interactions are common due to the large number of drugs used in patients, and antiinfectives are frequently involved in interactions due to ...
Ayse Gunay, Eren Demirpolat, Ali Unal
doaj   +1 more source

Caregivers Knowledge of Post Autologous Bone Marrow TransplantationPatients at Home [PDF]

Egyptian Journal of Health Care, 2019
Background: Autologous bone marrow transplantation is an intervention for a variety of life-threatening diseases. Stem cells transplantation procedures continue to be improved, making transplantation a treatment option for many patients.
Hemat Abd-El-Moneem El-Sayied, Nawal Soliman, Asmaa Farouk Mohamed   +2 more
doaj   +1 more source

Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results

Frontiers in Immunology, 2021
BackgroundMaintenance treatment after autologous bone marrow transplantation in multiple myeloma improves the outcome of patients. We designed a phase II clinical trial to evaluate the treatment with IL2 and zoledronate after autologous bone marrow ...
Rita Fazzi, Iacopo Petrini, Nicola Giuliani, Riccardo Morganti, Giovanni Carulli, Benedetta Dalla Palma, Laura Notarfranchi, Sara Galimberti, Gabriele Buda   +8 more
doaj   +1 more source

Clinico-morphological characteristics of patients with systemic scleroderma before and after autologous bone marrow-derived mesenchymal stem cells transplantation [PDF]

Ķazaķstannyṇ Klinikalyķ Medicinasy, 2018
The article describes the clinical and morphological dynamics of systemic scleroderma diffuse form on the background of autologous bone marrow mesenchymal stem cells transplantation.
Natalya Krivoruchko, Aigerim Imanberdiyeva, Manarbek Askarov, Galina Fedotovskikh, Galiya Shaimardanova, Saltanat Tuganbekovа   +5 more
doaj   +1 more source

Loss of quiescence and impaired function of CD34+/CD38low cells one year following autologous stem cell transplantation

Haematologica, 2013
Patients who have undergone autologous stem cell transplantation are subsequently more susceptible to chemotherapy-induced bone marrow toxicity. In the present study, bone marrow primitive progenitor cells were examined one year after autologous stem ...
Carolien M. Woolthuis, Annet Z. Brouwers-Vos, Gerwin Huls, Joost Th. M. de Wolf, Jan Jacob Schuringa, Edo Vellenga   +5 more
doaj   +1 more source

Post Autologous Bone Marrow Transplant Associated With a Resultant Mixed Polyclonal/Monoclonal Hyper-IgG3

Allergy & Rhinology, 2020
There have been few studies illustrating the post immunological phenotype of patients receiving autologous bone marrow transplant (ABMT) for the treatment of diffuse large B-cell lymphoma. High-dose chemotherapy and autologous bone marrow transplantation
Lauren Fill DO, Marija Rowane OMS-II, Kelsey Graven DO, Neha Sanan DO, Shan Shan Wu DO, Robert W. Hostoffer DO   +5 more
doaj   +1 more source

Plegia to walking: AHSCBMT in severe NMOSD relapse

BMJ Neurology Open, 2020
Objectives Neuromyelitis optica is a devastating, relapsing, inflammatory, autoimmune disorder characterised in large part by attacks of optic neuritis and transverse myelitis causing blindness and plegia in many patients.
Nicola Carlisle, Parameswaran Hari, Staley Brod   +2 more
doaj   +1 more source

A Comparison of Allogeneic and Autologous Hematopoietic Stem Cell Transplantation for Acute Myeloblastic Leukemia [PDF]

International Journal of Hematology-Oncology and Stem Cell Research, 2009
Introduction: Acute Myelogenous Leukemia (AML) is a clonal  malignant disease of hematopoietic tissue. The early use of  Hematopoietic Stem Cell Transplantation (HSCT) for AML was for patients with advanced stages of disease, usually while in relapse, in
Ardeshir Ghavamzadeh, Atefeh Masnavi, Farnaz Khatami, Arash Jalali, Kamran Alimoghaddam   +4 more
doaj   +1 more source

Reversal of Graft-Versus-Host Disease with Infusion of Autologous Bone Marrow

Cell Transplantation, 1994
Graft-versus-host disease (GVHD) remains a major complication of bone marrow transplantation. This report describes reversal of GVHD by infusion of stored recipient bone marrow following combined liver-bone marrow allotransplantation.
Camillo Ricordi M.D., Anreas G. Tzakis, Adriana Zeevi, Witold B. Rybka, Anthony J. Demetris, Paulo A.C. Fontes, Michael A. Nalesnik, Massimo Trucco, Ferdinand O. Ukah, Edward D. Ball, Edward E. Mullen, Ignazio R. Marino, John J. Fung, Thomas E. Starzl   +13 more
doaj   +1 more source